临床实践中的土耳其现实生活中的心房动:TRAFFIC研究的两年临床结果
Can Yücel Karabay1, Mehmet Ali Astarcıoğlu2, Fahriye Vatansever Ağca3
1Department of Cardiology, Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital, İstanbul, Türkiye.
Anatolian journal of cardiology
|December 29, 2025
概括
在土耳其的TRAFFIC研究揭示了当代非膜心房动 (NVAF) 患者数据. 结果显示事件发生率低于历史队列,但死亡率仍然存在,强调除了抗凝血治疗之外的护理.
科学领域:
- 心脏病学 心脏病学
- 公共卫生 公共卫生
- 流行病学 流行病学
背景情况:
- 心房动 (AF) 构成重大公共卫生风险,包括血栓栓塞和死亡率.
- 在土耳其对AF的非维生素K对抗剂口服抗凝剂 (NOAC) 使用的现实数据有限.
- 土耳其临床实践中的真实生活心房动 (TRAFFIC) 研究解决了这一数据缺口.
研究的目的:
- 描述土耳其非膜性肌痛性肌痛 (NVAF) 患者的人口特征.
- 分析NVAF患者的风险概况,治疗模式和临床结果.
- 提供有关土耳其NVAF管理和结果的当代真实数据.
主要方法:
- 一个国家,前性,多中心观察注册表 (TRAFFIC) 注册了1659名NVAF患者.
- 数据收集包括人口统计,并发症,风险评分 (CHA2DS2-VASc,HAS-BLED),AF亚型和抗血栓治疗.
- 两年的随访评估了缺血性中风/全身栓塞 (SE),严重出血和全因死亡率.
主要成果:
- 患者的中位数年龄为70岁,其中48%为女性;大多数患者的CHA2DS2-VASc和HAS-BLED分数介于中等和中等.
- 非维生素K对抗剂口服抗凝剂 (NOACs) 是主导治疗 (65%),反映了风险概况.
- 在两年内,所有原因的死亡率为8.9%,缺血性中风/SE2.4%和严重出血1.3%. 年龄,心力衰竭和糖尿病预测死亡率.
结论:
- 交通研究提供了关于土耳其NVAF管理的最新见解,事件发生率低于历史数据.
- 观察到的结果与国际注册表相似.
- 持续的死亡率强调了除了抗凝药之外,需要全面的AF护理策略.
相关概念视频
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
430
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
430
Atherosclerosis III: Management
291
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
291
Acute Coronary Syndrome III: Diagnostic Studies
194
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
194
Aneurysm II: Clinical Manifestations and Diagnostic Studies
193
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
193
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
439
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
439
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
266
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
266


